Sanofi US Services INC.

pharmaceutical manufacturer

Based in NJ

🤖

AI Overview

With $1.4M in lobbying spend across 28 quarterly filings, Sanofi US Services INC. is a significant lobbying presence.

$1.4M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
10
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$120K
2019$200K
2020$200K
2021$150K
2022$200K
2023$200K
2024$150K
2025$150K

Lobbying Firms

CROSSROADS STRATEGIES, LLC

What They Lobby For

  • Implementation of H.R.1, Tax Cuts and Jobs Act (P.L.115-97).
  • Part D Medicare Program (including Coverage Gap and other offsets).
  • Issues related to Over the Counter (OTC) Monograph reform, influenza, and drug pricing; S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S.2434, Animal Drug and Animal Generic Drug User Fee Amendments of 2018.
  • H.R.5786/S.3024, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019; S.3158/House Draft, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R.5961/S.2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019.
  • Part D Medicare Program (including Coverage Gap and other offsets). Medicare Part B reimbursement.
  • Issues related to Over the Counter (OTC) Monograph reform, influenza, and drug pricing; S.2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; H.R.6378, To reauthorize certain programs under the Pandemic and All-Hazards Preparedness Reauthorization Act; S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act; H.R.5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018.
  • H.R.5786/S.3024, Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2019; S.3158/H.R.6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R.5961/S.2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; H.R.5895, Energy and Water, Legislative Branch, and Military Construction and Veterans Affairs Appropriations Act, 2019 (P.L.115-244); H.R.6147, Interior, Environment, Financial Services and General Government, Agriculture, Rural Development, Food and Drug Administration, and Transportation, Housing and Urban Development Appropriations Act, 2019; H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245).
  • General issues related to Medicare and Medicaid, such as: Part D Medicare Program (including Coverage Gap and other offsets) and Medicare Part B reimbursement. Proposed Part B IPI Demonstration Project.
  • Issues related to Over the Counter (OTC) Monograph reform, influenza, and drug pricing; S.2852/H.R.6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; S.2434/H.R.5554, Animal Drug and Animal Generic Drug User Fee Amendments of 2018 (P.L.115-234); S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act; H.R.5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018.
  • H.R.5961/S.2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; H.R.5895, Energy and Water, Legislative Branch, and Military Construction and Veterans Affairs Appropriations Act, 2019 (P.L.115-244); H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019 (P.L.115-245).

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.